242 related articles for article (PubMed ID: 27792451)
1. lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1.
Liu X; Gan B
Cell Cycle; 2016 Dec; 15(24):3471-3481. PubMed ID: 27792451
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Regulates the Progression of Colorectal Cancer via LncRNA NBR2/AMPK Pathway.
Yu H; Xie Y; Zhou Z; Wu Z; Dai X; Xu B
Technol Cancer Res Treat; 2019; 18():1533033819870781. PubMed ID: 31888414
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NBR2 suppresses the progression of colorectal cancer by downregulating miR-19a to regulate M2 macrophage polarization.
Yang X; Luo Y; Li M; Jin Z; Chen G; Gan C
Chin J Physiol; 2023; 66(6):546-557. PubMed ID: 38149567
[TBL] [Abstract][Full Text] [Related]
4. NBR2-GLUT1 axis regulates cancer cell sensitivity to biguanides.
Zhang X; Lin HK
Cell Cycle; 2017 Feb; 16(3):249-250. PubMed ID: 27929708
[No Abstract] [Full Text] [Related]
5. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress.
Liu X; Xiao ZD; Han L; Zhang J; Lee SW; Wang W; Lee H; Zhuang L; Chen J; Lin HK; Wang J; Liang H; Gan B
Nat Cell Biol; 2016 Apr; 18(4):431-42. PubMed ID: 26999735
[TBL] [Abstract][Full Text] [Related]
6. NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis.
Wang CS; Zhang XB; Zhu XT; Chen RS
Neoplasma; 2022 Sep; 69(5):1165-1174. PubMed ID: 35951458
[TBL] [Abstract][Full Text] [Related]
7. C-Phycocyanin Suppresses Cell Proliferation and Promotes Apoptosis by Regulating the AMPK Pathway in NCL-H292 Non-Small Cell Lung Cancer Cells.
Chaowen H; Dongxuan H; Dongsheng H; Jianfeng P; Fan Y; Yahui C; Xiaohua L
Folia Biol (Praha); 2022; 68(1):16-24. PubMed ID: 36201854
[TBL] [Abstract][Full Text] [Related]
8. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
[TBL] [Abstract][Full Text] [Related]
9. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake.
Ginion A; Auquier J; Benton CR; Mouton C; Vanoverschelde JL; Hue L; Horman S; Beauloye C; Bertrand L
Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H469-77. PubMed ID: 21602475
[TBL] [Abstract][Full Text] [Related]
11. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG
Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468
[TBL] [Abstract][Full Text] [Related]
12. lncRNA NBR2 attenuates angiotensin II-induced myocardial hypertrophy through repressing ER stress via activating LKB1/AMPK/Sirt1 pathway.
Zhu C; Wang M; Yu X; Shui X; Tang L; Chen Z; Xiong Z
Bioengineered; 2022 May; 13(5):13667-13679. PubMed ID: 35703318
[TBL] [Abstract][Full Text] [Related]
13. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
[TBL] [Abstract][Full Text] [Related]
14. LncRNA NBR2 aggravates hepatoblastoma cell malignancy and promotes cell proliferation under glucose starvation through the miR-22/TCF7 axis.
Zhu C; He X; Chen K; Huang Z; Yao A; Tian X; You Y; Zeng M
Cell Cycle; 2021; 20(5-6):575-590. PubMed ID: 33651649
[TBL] [Abstract][Full Text] [Related]
15. IKK promotes cytokine-induced and cancer-associated AMPK activity and attenuates phenformin-induced cell death in LKB1-deficient cells.
Antonia RJ; Baldwin AS
Sci Signal; 2018 Jul; 11(538):. PubMed ID: 29991651
[TBL] [Abstract][Full Text] [Related]
16. Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
Wu T; Zhou S; Qin M; Tang J; Yan X; Huang L; Huang M; Deng J; Xiao D; Hu X; Wu J; Yang X; Li G
FEBS Open Bio; 2021 May; 11(5):1440-1451. PubMed ID: 33742560
[TBL] [Abstract][Full Text] [Related]
17. 5'-AMP-activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes.
Lee CT; Ussher JR; Mohammad A; Lam A; Lopaschuk GD
Can J Physiol Pharmacol; 2014 Apr; 92(4):307-14. PubMed ID: 24708213
[TBL] [Abstract][Full Text] [Related]
18. An lncRNA switch for AMPK activation.
Liu X; Xiao ZD; Gan B
Cell Cycle; 2016 Aug; 15(15):1948-9. PubMed ID: 27152502
[No Abstract] [Full Text] [Related]
19. MicroRNA-451 regulates AMPK/mTORC1 signaling and fascin1 expression in HT-29 colorectal cancer.
Chen MB; Wei MX; Han JY; Wu XY; Li C; Wang J; Shen W; Lu PH
Cell Signal; 2014 Jan; 26(1):102-9. PubMed ID: 23899558
[TBL] [Abstract][Full Text] [Related]
20. Ppm1E is an in cellulo AMP-activated protein kinase phosphatase.
Voss M; Paterson J; Kelsall IR; MartÃn-Granados C; Hastie CJ; Peggie MW; Cohen PT
Cell Signal; 2011 Jan; 23(1):114-24. PubMed ID: 20801214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
